Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.LFA Welcomes Latest Lupus Nephritis Phase III Study Results
Reportedly, the Phase III study results released by Vifor Pharma and Roche reached the primary endpoint of delaying treatment failure in patients with lupus nephritis who had successfully
Reportedly, the Phase III study results released by Vifor Pharma and Roche reached the primary endpoint of delaying treatment failure in patients with lupus nephritis who had successfully
China Nuokang has posted a net income of RMB17.07m, or RMB0.11 per diluted share, compared to RMB11.19m, or RMB0.05 per diluted share, for the prior year period. Operating
The sales for Protidiet increased compared to the same quarter of 2009 due to the higher demand for Ranaz’s products in US. The sales for ProtiLife decreased, compared
Sinovac said that, as part of the bidding process, the Beijing CDC will evaluate potential suppliers and assigns scores for different factors, including product quality, service and price.
The option to license the breast cancer vaccine technology can be exercised after Phase I clinical trials under terms agreed between Mayo Clinic and TapImmune. Reportedly, upon IND
According to Amgen, Prolia’s approval is based on a pivotal three-year Phase 3 study involving 7,808 postmenopausal women with osteoporosis. Amgen claimed that Prolia, the first and only
YAZ is a progesterone and estrogen combination birth control pill. Yaz is used for preventing pregnancy. Teva Pharma has claimed that, as the first company to file an
CoaguSense PT/INR monitoring system consists of a low-cost meter and disposable test strip. Medical professionals can order the system through Abbott Point of Care, which formed an exclusive
Upon completion of the transaction, Watson intends to immediately commence marketing Crinone and Prochieve for approved indications in the US to reproductive endocrinologists and Ob/Gyns through the existing
Scientists at Alnylam and collaborators from Mount Sinai School of Medicine have published the research findings in the journal Proceedings of the National Academy of Sciences (PNAS). Reportedly,